Abstract: Extracorporeal shockwave therapy (ESWT) and platelet-rich plasma (PRP) are common treatments for soft tissue injuries in horses. Shockwave triggers cell specific responses to promote healing. Growth factors released from PRP also promote healing. It has been hypothesized that greater growth factor release would amplify the healing process. The combination of ESWT and PRP could promote healing in injured tendons and ligaments in the horse. The objective of this study was to determine if application of shockwaves to PRP samples increases the concentration of transforming growth factor-β1 (TGF-β1) and platelet-derived growth factor ββ (PDGF-ββ) released from the platelets in vitro. Methods: PRP was produced from blood drawn from six horses. The PRP from each horse was exposed to the following treatments: (1) positive control (freeze-thaw cycle), (2) untreated negative control, or shockwaves with either (3) a "standard probe" (ESWT-S) with a 2 cm focal width and medium energy density or (4) a "power probe" (ESWT-P) with a 1 cm focal width and high energy density. After each treatment, the samples were centrifuged, and the supernatant was harvested. The supernatant was then used for growth factor quantification via commercially available ELISA kits for TGF-β1 and PDGF-ββ. Results: Concentrations of TGF-β1 and PDGF-ββ in PRP that underwent a freeze-thaw cycle were significantly increased compared with all other treatments. Both ESWT-S and ESWT-P resulted in significantly increased TGF-β1 concentrations, 46 and 33%, respectively, when compared with the negative control. Both ESWT-S and ESWT-P resulted in significantly increased PDGF-ββ concentrations, 219 and 190%, respectively, when compared with the negative control. Conclusions: These data indicate that the application of ESWT to PRP increases the expression of growth factors in vitro. This suggests that the combination therapy of local PRP injection followed by ESWT may stimulate release of growth factors from platelets after they have been injected into the area of injury. Conclusions: The combination of PRP and ESWT might result in synergism of two modalities previously utilized individually for tendon and ligament injuries in horses.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The aim of this study was to discover if ESWT can increase the release of growth factors from PRP, which could potentially improve the healing process. The specific growth factors examined were transforming growth factor-β (TGF-β) and platelet-derived growth factor ββ (PDGF-ββ).
Methods
The researchers created PRP from blood drawn from six horses.
Four different treatments were applied to the PRP: a positive control (freeze-thaw cycle), a negative control (no treatment), shockwaves with a “standard probe” (lower energy), and shockwaves with a “power probe” (higher energy).
After each treatment, the PRP samples were centrifuged and the liquid part (supernatant) was collected for analysis.
The researchers used ELISA kits to quantify the amount of TGF-β and PDGF-ββ in the supernatant.
Results
The freeze-thaw cycle (positive control) significantly increased the concentration of both growth factors compared to the other treatments.
The ESWT treatments also significantly increased the concentrations of the growth factors compared to the negative control. The standard probe increased TGF-β by 46% and PDGF-ββ by 219%. Similarly, the power probe increased TGF-β by 33% and PDGF-ββ by 190%.
Conclusions
The study demonstrated that the application of ESWT to PRP increases the release of growth factors, which underpins its therapeutic potential for healing soft tissue injuries in horses.
The researchers suggest that a combination therapy of injecting PRP into the injury site, followed by ESWT, may stimulate the release of growth factors from platelets, thus enhancing healing.
The combination of PRP and ESWT, both used individually for such injuries before, might show a synergistic effect in promoting healing in horses’ tendons and ligaments.
Cite This Article
APA
Seabaugh KA, Thoresen M, Giguère S.
(2017).
Extracorporeal Shockwave Therapy Increases Growth Factor Release from Equine Platelet-Rich Plasma In Vitro.
Front Vet Sci, 4, 205.
https://doi.org/10.3389/fvets.2017.00205
Chamberlain GA, Colborne GR. A review of the cellular and molecular effects of extracorporeal shockwave therapy. Vet Comp Orthop Traumatol (2016) 29(2):99–107.
Bazzano M, Piccione G, Giannetto C, Tosto F, Di Pietro S, Giudice E. Platelet rich plasma intralesional injection as bedside therapy for tendinitis in athletic horse. Acta Sci Vet (2013) 41:1–7.
Zuffova K, Krisova S, Zert Z. Platelet rich plasma treatment of superficial digital flexor tendon lesions in racing thoroughbreds. Vet Med (2013) 58(4):230–9.
Romagnoli N, Rinnovati R, Ricciardi G, Lambertini C, Spinella G, Spadari A. Clinical evaluation of intralesional injection of platelet-rich plasma for the treatment of proximal suspensory ligament desmitis in horses. J Equine Vet Sci (2015) 35(2):141–6.
Harrison S, Vavken P, Kevy S, Jacobson M, Zurakowski D, Murray MM. Platelet activation by collagen provides sustained release of anabolic cytokines. Am J Sports Med (2011) 39(4):729–34.
Dietz-Laursonn K, Beckmann R, Ginter S, Radermacher K, de la Fuente M. In-vitro cell treatment with focused shockwaves-influence of the experimental setup on the sound field and biological reaction. J Ther Ultrasound (2016) 4:10.
Zell K, Sperl JI, Vogel MW, Niessner R, Haisch C. Acoustical properties of selected tissue phantom materials for ultrasound imaging. Phys Med Biol (2007) 52(20):N475–84.
Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg (2004) 114(6):1502–8.
Lee JW, Kwon OH, Kim TK, Cho YK, Choi KY, Chung HY. Platelet-rich plasma: quantitative assessment of growth factor levels and comparative analysis of activated and inactivated groups. Arch Plast Surg (2013) 40(5):530–5.
Del Bue M, Ricco S, Conti V, Merli E, Ramoni R, Grolli S. Platelet lysate promotes in vitro proliferation of equine mesenchymal stem cells and tenocytes. Vet Res Commun (2007) 31(Suppl 1):289–92.
Sun D, Junger WG, Yuan C, Zhang W, Bao Y, Qin D. Shockwaves induce osteogenic differentiation of human mesenchymal stem cells through ATP release and activation of P2X7 receptors. Stem Cells (2013) 31(6):1170–80.
Janout H, Flatscher J, Winkler SM, Slezak P, Slezak C. Use of Secondary Reflectors for Enhanced ESWT Treatment of the Penis. Biomedicines 2025 Aug 13;13(8).
Daneshwar D, Lee Y, Nordin A. Stem cell assisted low-intensity shockwave for erectile dysfunction treatment: Current perspective. Regen Ther 2024 Jun;26:1150-1158.
Morya VK, Shahid H, Lang J, Kwak MK, Park SH, Noh KC. Advancements in Therapeutic Approaches for Degenerative Tendinopathy: Evaluating Efficacy and Challenges. Int J Mol Sci 2024 Nov 4;25(21).
Rola P, Włodarczak A, Barycki M, Doroszko A. Use of the Shock Wave Therapy in Basic Research and Clinical Applications-From Bench to Bedsite. Biomedicines 2022 Feb 28;10(3).
Rola P, Włodarczak A, Kulczycki JJ, Barycki M, Furtan Ł, Pęcherzewski M, Szudrowicz M, Włodarczak S, Doroszko A, Lesiak M. Efficacy and safety of shockwave intravascular lithotripsy (S-IVL) in calcified unprotected left main percutaneous coronary intervention - short-term outcomes. Postepy Kardiol Interwencyjnej 2021 Dec;17(4):344-348.
Fan T, Zhou X, He P, Zhan X, Zheng P, Chen R, Li R, Li R, Wei M, Zhang X, Huang G. Effects of Radial Extracorporeal Shock Wave Therapy on Flexor Spasticity of the Upper Limb in Post-stroke Patients: Study Protocol for a Randomized Controlled Trial. Front Neurol 2021;12:712512.